Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Mahdi Aghili
Mahdi Aghili

Professor of Radiation Oncology

Department Radiotherapy

School of Medicine

Imam Khomeini Hospital Complex,Cancer Institute

Radiation Oncology Research Center

Tehran University of Medical Sciences

All Documents
1. Botulinum Toxin (Dysport) to Prevent Radiation-Induced Dysfunction of Salivary Glands in Head and Neck Cancer, Cancer Reports (2026)
2. Impact of the Surgery to Radiotherapy Interval on Oncological Outcomes in Squamous Cell Carcinoma of the Oral Tongue, Discover Oncology (2026)
3. Phase Ii Randomized Trial of 41.4 Gy Vs. 50.4 Gy in Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer, Clinical and Translational Radiation Oncology (2026)
4. Analysis of Patients With Locally Advanced Rectal Cancer Given Neoadjuvant Radiochemotherapy With or Without Rt Dose Intensification: A Multicenter Retrospective Study – Atlantis Part I, Radiotherapy and Oncology (2025)
5. Cd8-Positive Lymphocyte Infiltration As a Marker of Anti-Tumor Immune Response in Rectal Cancer: Pre- and Post-Neoadjuvant Radiotherapy Comparison, Clinical and Translational Radiation Oncology (2025)
6. Comparison of the Clinical Response in Total Neoadjuvant Treatment With Long-Term or Short-Term Chemoradiotherapy Followed by Consolidation Chemotherapy in Patients With Locally Advanced Rectal Cancer (Tehran); the Protocol for a Randomized Controlled Clinical Trial, Cancer Medicine (2025)
7. Ectopic Expression of Mir-34A/-328 Sensitizes Breast Cancer Stem Cells to Gamma Rays/Doxorubicin by Bcl2/Abcg2 Targeting, Molecular Biology Reports (2025)
8. Evaluating the Breast Cancer Quality of Care Indicators in Iran; Multicenter Study, BMC Cancer (2025)
9. Long-Term Oncologic Outcomes of High-Dose-Rate Interstitial Brachytherapy (Interventional Radiotherapy) in Oral Tongue Squamous Cell Carcinoma; 15 Years of Experience From a Tertiary Cancer Center, Brachytherapy (2025)
10. Rt for the Management of Locally Advanced Rectal Cancer: Don't Throw the Baby With the Bath Water!, Radiotherapy and Oncology (2025)
11. Short-Course Versus Long-Course Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: Long-Term Results of a Randomized Controlled Trial, International Journal of Colorectal Disease (2025)
12. Socioeconomic Disparities Impacting Breast Cancer Care and Survival in Iran, Scientific Reports (2025)
13. Socioeconomic Disparities Impacting Breast Cancer Care and Survival in Iran, Scientific Reports (2025)
14. “Colorectal Cancer Care Quality in a Developing Country: Insights From a Comparison of Teaching and Non-Teaching Hospitals in Iran”, PLOS ONE (2025)
15. Duloxetine to Prevent Neuropathy in Breast Cancer Patients Under Paclitaxel Chemotherapy (A Double-Blind Randomized Trial), Supportive Care in Cancer (2024)
16. Efficacy of Adjuvant External Beam Radiotherapy and Brachytherapy in Squamous Cell Carcinoma of Oral Tongue: Long-Term Outcomes, Journal of Contemporary Brachytherapy (2024)
17. Global, Regional, and National Quality of Care Index (Qci) of Gastric Cancer: A Systematic Analysis for the Global Burden of Disease Study 1990-2017, Journal of Gastrointestinal Cancer (2024)
18. Optimal Sequence for Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: An Evidence-Based Review, Cancer Medicine (2024)
19. Outcomes of Neoadjuvant Chemoradiotherapy in T4 Rectal Cancer Patients: A Real-World Single Institution Experience, Radiation Oncology Journal (2024)
20. Role of Intravoxel Incoherent Motion and Dynamic-Contrast-Enhanced Perfusion in Response Prediction of Patients With Colorectal Cancer After Neoadjuvant Chemotherapy, Asian Pacific Journal of Cancer Prevention (2024)
21. Role of Oxaliplatin in the Neoadjuvant Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review of Evidence, Clinical Medicine Insights: Oncology (2024)
22. Short Course Brachytherapy in Locally Advanced Cervical Cancer; Safety and Response Rate, Asian Pacific Journal of Cancer Prevention (2024)
23. Short-Term and Long-Term Oncological Outcomes of Chemoradiotherapy for Rectal Cancer Patients With or Without Oxaliplatin: A Propensity Score-Matched Retrospective Analysis, Radiation Oncology (2024)
24. The Protective Effect of Vitamin D on Ovarian Reserve and Anti-Mullerian Hormone in Patients Undergoing Chemotherapy for Breast Cancer, a Randomized Phase Ιι Clinical Trial, Cancer Reports (2024)
25. The Role of Histology on the Outcome of Sinonasal Carcinomas Treated With Radiotherapy: A Single Institution Experience, Radiation Oncology Journal (2024)
26. The Role of Lovastatin in Curative Chemoradiotherapy for Patients With Head and Neck Cancer: A Randomized Trial, Middle East Journal of Cancer (2024)
27. A Structural Model Explaining the Effect of Cognitive Emotion Regulation on Fear of Cancer Recurrence in Breast Cancer Survivors: The Mediating Roles of Illness Perception and Psychological Well-Being, Archives of Breast Cancer (2023)
28. Complication and Response Assessment of High-Dose-Rate Endorectal Brachytherapy Boost in Neo-Adjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer With Long-Term Outcomes, Journal of Contemporary Brachytherapy (2023)
29. Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial, Journal of Gastrointestinal Cancer (2023)
30. Endocervical Adenocarcinoma Implantation in Episiotomy Scar: A Case Report and Review of The Literature, Journal of Medical Case Reports (2023)
31. Expansion of the Quality of Care Index on Breast Cancer and Its Risk Factors Using the Global Burden of Disease Study 2019, Cancer Medicine (2023)
32. The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors, Iranian Journal of Breast Diseases (2023)
33. The Role of External Beam Radiation Therapy in the Management of Thyroid Carcinomas: A Retrospective Study in Iran Cancer Institute, Cancer Reports (2023)
34. The State-Of-The-Art Technic of Stereotactic Radioablation for the Treatment of Cardiac Arrhythmias: An Overview, Health Science Reports (2023)
35. Value of Conventional Mri, Dce-Mri, and Dwi-Mri in the Discrimination of Metastatic From Non-Metastatic Lymph Nodes in Rectal Cancer: A Systematic Review and Meta-Analysis Study, Asian Pacific Journal of Cancer Prevention (2023)
36. Assessing Honey Jell® As a Treatment for Reducing Cancer-Related Fatigue in Breast Cancer Patients Undergoing Radiotherapy: Double Blind Phase Iii Clinical Trial, Archives of Breast Cancer (2022)
37. Comparison of Partial Laryngectomy Versus Radiotherapy for the Treatment of Early Glottic Carcinoma: Complications and Oncological Results: A Nonrandomized Clinical Trial, Acta Medica Iranica (2022)
38. Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y), Pharmacological Reports (2022)
39. Definitive Radiotherapy With or Without Concomitant or Induction Chemotherapy in Patients With Hypopharyngeal Squamous Cell Carcinoma: A Single Center Study in Iran, Middle East Journal of Cancer (2022)
40. Dose to Pelvic Lymph Nodes During Brachytherapy of Locally Advanced Cervical Cancer With 60Co Hdr Source, Brachytherapy (2022)
41. Long-Term Disease-Free Survival Following Salvage Brachytherapy for Recurrent Pediatric Rhabdomyosarcoma: Two Case Reports and Review of Relevant Literature, Brachytherapy (2022)
42. Long-Term Survival Rates of Patients With Nasopharyngeal Carcinoma Treated by Radiochemotherapy: A Retrospective Cohort Study, Egyptian Journal of Otolaryngology (2022)
43. Radiosensitization of Glioma Cells by Temozolomide (Tmz): A Colony Formation Assay, Journal of Biomedical Physics and Engineering (2022)
44. Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells, Pharmacological Reports (2022)
45. Safety and Efficacy of Salvage High-Dose Rate Brachytherapy for Prostate-Bed Recurrences Following Radical Prostatectomy and External Beam Radiotherapy, International Urology and Nephrology (2022)
46. A Comparison Between 2D and 3D Planning of High-Dose-Rate Vaginal Cuff Brachytherapy in Patients With Stage I-Ii Endometrial Cancer Using Cobalt-60, Journal of Contemporary Brachytherapy (2021)
47. Cervical Cancer Brachytherapy Amid the Pandemic: A Single Institutional Case Series, Onkologia i Radioterapia (2021)
48. Current Approaches in Intensification of Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review, Radiation Oncology Journal (2021)
49. Durable Complete Response to Pembrolizumab in Microsatellite Stable Colorectal Cancer, DARU# Journal of Pharmaceutical Sciences (2021)
50. Evaluation of Dose Distribution in Optimized Stanford Total Skin Electron Therapy (Tset) Technique in Rando Anthropomorphic Phantom Using Ebt3 Gafchromatic Films, Journal of Biomedical Physics and Engineering (2021)
51. Improvement in the Survival of Esophageal Cancer Patients at Cancer Institute of Iran After Implementation of the Neo-Adjuvant Chemo-Radiation: Retrospective Cohort Study, Middle East Journal of Cancer (2021)
52. Low-Dose Whole-Lung Irradiation in Severe Covid-19 Pneumonia: A Controlled Clinical Trial, Journal of Medical Radiation Sciences (2021)
53. The Efficacy of Celecoxib During Chemoradiation in Locally Advanced Head and Neck Carcinoma; a Phase 2 Randomized Placebo Control Clinical Trial, International Journal of Cancer Management (2021)
54. Brachytherapy During the Coronavirus Disease 2019 – Lessons From Iran, Brachytherapy (2020)
55. Effectiveness of Acupuncture Treatment on Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized, Assessor-Blinded, Controlled Trial, Pain Research and Management (2020)
56. Modifications in Breast Cancer Guidelines in Covid-19 Pandemic; an Iranian Consensus, Archives of Breast Cancer (2020)
57. Multimodality Treatment in Unresectable Cholangiocarcinoma, Journal of Contemporary Brachytherapy (2020)
58. Radiotherapy and Covid-19: Practical Recommendations From Iran, Radiotherapy and Oncology (2020)
59. Short-Course Versus Long-Course Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: Preliminary Results of a Randomized Controlled Trial, Radiation Oncology Journal (2020)
60. Accelerated Partial Breast Irradiation: A New Strategy for Early-Stage Breast Cancer, Archives of Breast Cancer (2019)
61. Efficacy of Gabapentin for the Prevention of Paclitaxel Induced Peripheral Neuropathy: A Randomized Placebo Controlled Clinical Trial, Breast Journal (2019)
62. Esophagectomy Complications and Mortality in Esophageal Cancer Patients, a Comparison Between Trans-Thoracic and Trans-Hiatal Methods, Electronic Journal of General Medicine (2019)
63. Estimating the Cost of Illness of Prostate Cancer in Iran, Clinical Therapeutics (2019)
64. Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients With Endometrial Cancer, Asian Pacific Journal of Cancer Prevention (2019)
65. Analysis of Micrornas Expression Changes in Human Breast Cancer Cell Lines Following Exposure to Ionizing Radiation, International Journal of Radiation Research (2018)
66. Concurrent Chemo- Radiobrachytherapy With Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer, Asian Pacific Journal of Cancer Prevention (2018)
67. High-Dose-Rate Brachytherapy in Treatment of Non-Melanoma Skin Cancer of Head and Neck Region: Preliminary Results of a Prospective Single Institution Study, Journal of Contemporary Brachytherapy (2018)
68. Investigation of Electron Boost Radiotherapy in Patients With Breast Cancer: Is a Direct Electron Field Optimal?; [Enquete Sur Le Boostpar Electrons Chez Les Patients Atteints De Cancer Du Sein : Un Faisceau Direct Est-Il Optimal ?], Cancer/Radiotherapie (2018)
69. Preoperative Short Course Radiotherapy With Concurrent and Consolidation Chemotherapies Followed by Delayed Surgery in Locally Advanced Rectal Cancer: Preliminary Results, Radiation Oncology Journal (2018)
70. Addition of Oxaliplatin to Neoadjuvant Radiochemotherapy in Mri-Defined T3, T4 or N+ Rectal Cancer: A Randomized Clinical Trial, Asia-Pacific Journal of Clinical Oncology (2017)
71. Adjuvant High-Dose-Rate Brachytherapy in the Management of Oral Cavity Cancers: 5 Years of Experience in Iran, Journal of Contemporary Brachytherapy (2017)
72. Analysis of the Effective Factors in Physician’S Truth Telling to Cancer Patients in Iran, Tehran University Medical Journal (2017)
73. Outcomes of Neoadjuvant Radiochemotherapy of Locally Advanced Rectal Adenocarcinoma: Results of 8 Year Experience in Iran Cancer Institute, International Journal of Cancer Management (2017)
74. Travel Burden for Cancer Patients in Iran: Analysis of 1700 Patients From the Cancer Institute of Iran, Archives of Iranian Medicine (2017)
75. A Time for Optimism? the State of Radiation Oncology in Iran, International Journal of Radiation Oncology Biology Physics (2016)
76. How Accurate Is Mri to Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer?, Tehran University Medical Journal (2016)
77. Morbidity and Mortality Following Short Course Preoperative Radiotherapy in Rectal Carcinoma, Acta Medica Iranica (2015)
78. Neoadjuvant Chemotherapy for Locally Advanced Squamous Carcinoma of Oral Cavity: A Pilot Study, Acta Medica Iranica (2015)